proNGF Measurement in Cerebrospinal Fluid Samples of a Large Cohort of Living Patients With Alzheimer's Disease by a New Automated Immunoassay

The discovery of new biomarkers for Alzheimer's disease (AD) is essential for an accurate diagnosis, to conceive new strategies of treatments, and for monitoring the efficacy of potential disease-modifying therapies in clinical trials. proNGF levels in the cerebrospinal fluid (CSF) represent a...

Descripción completa

Detalles Bibliográficos
Autores principales: Malerba, Francesca, Arisi, Ivan, Florio, Rita, Zecca, Chiara, Dell'Abate, Maria Teresa, Bruni Ercole, Bruno, Camerini, Serena, Casella, Marialuisa, Logroscino, Giancarlo, Cattaneo, Antonino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579109/
https://www.ncbi.nlm.nih.gov/pubmed/34776928
http://dx.doi.org/10.3389/fnagi.2021.741414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579109/
https://www.ncbi.nlm.nih.gov/pubmed/34776928
http://dx.doi.org/10.3389/fnagi.2021.741414

Ejemplares similares